These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13421789)

  • 21. The clinical management of leukemias.
    BURCHENAL JH
    Cancer Res; 1954 Oct; 14(9):615-24. PubMed ID: 13209532
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of lymphomas and leukemias.
    BLOCK M
    Rocky Mt Med J; 1959 Jun; 56(6):59-63. PubMed ID: 13658893
    [No Abstract]   [Full Text] [Related]  

  • 23. Leukemias. Foreword.
    Leikin JB
    Dis Mon; 2008 Apr; 54(4):201. PubMed ID: 18346478
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prednisone therapy of infantile leukemias; case reports].
    GRANATA G; FANTUZZI B
    Minerva Pediatr; 1957 Nov; 9(47):1419-24. PubMed ID: 13516919
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of leukemias; indications for radiotherapy].
    FERNANDES DA COSTA JUNIOR A
    Rev Bras Cir; 1954 Dec; 28(6):459-72. PubMed ID: 14372255
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunotherapeutic peptide vaccination with leukemia-associated antigens.
    Rusakiewicz S; Molldrem JJ
    Curr Opin Immunol; 2006 Oct; 18(5):599-604. PubMed ID: 16870418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias.
    MEZA ARRAU C; NIJAMKIN A
    Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
    Pfeifer H; Wassmann B; Hofmann WK; Komor M; Scheuring U; Brück P; Binckebanck A; Schleyer E; Gökbuget N; Wolff T; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2003 Oct; 9(13):4674-81. PubMed ID: 14581336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative evaluation of the effectiveness of certain therapeutic methods in chronic leukemias; roentgen rays, radioactive phosphorus, urethane, embichine, arsenic, myleran. V].
    SHERMAN SI; KUZ'MIN DS; ROZANOVA LM; KISELEVA AN; POVERGO NS; VAKULENKO AD
    Probl Gematol Pereliv Krovi; 1959 May; 4(5):14-8. PubMed ID: 13658099
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative evaluation of the effectiveness of certain therapeutic methods in chronic leukemias; roentgen rays, radioactive phosphorus, urethane, embichine, arsenic, myleran. IV].
    SHERMAN SI; KUZ'MIN DS; ROZANOVA LM; KISELEVA AN; POVERGO NS; VAKULENKO AD
    Probl Gematol Pereliv Krovi; 1959 Jan; 4(1):17-20. PubMed ID: 13645525
    [No Abstract]   [Full Text] [Related]  

  • 31. Study of the hemostatic and coagulation defect in patients during roentgen therapy, with particular reference to leukemias and malignancies.
    DE NICOLA P; DI GUGLIELMO L; TIMOSSI G
    Am J Roentgenol Radium Ther Nucl Med; 1958 Jan; 79(1):142-8. PubMed ID: 13487900
    [No Abstract]   [Full Text] [Related]  

  • 32. [Quantitative changes of the cellular constituents of blood and bone marrow in chemotherapy of human leukemias].
    ALGENSTAEDT D
    Arztl Wochensch; 1959 Jun; 14(24):461-8. PubMed ID: 13670067
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple exploitable molecular targets for differentiation therapy of leukemias.
    Tsiftsoglou AS
    Leuk Res; 2008 Jan; 32(1):1-2. PubMed ID: 17629556
    [No Abstract]   [Full Text] [Related]  

  • 34. Eradication of leukemia stem cells as a new goal of therapy in leukemia.
    Ravandi F; Estrov Z
    Clin Cancer Res; 2006 Jan; 12(2):340-4. PubMed ID: 16428470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma cell dyscrasias and leukemias.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 2005; 22():343-89. PubMed ID: 16110620
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.
    Kataoka I; Kami M; Takahashi S; Kodera Y; Miyawaki S; Hirabayashi N; Okamoto S; Matsumoto N; Miyazaki Y; Morishita Y; Asai O; Maruta A; Yoshida T; Imamura M; Hamajima N; Matsuo K; Harada M; Mineishi S;
    Bone Marrow Transplant; 2004 Oct; 34(8):711-9. PubMed ID: 15361916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulation against leukemias and lymphomas: a realistic future treatment?
    Mittal S; Marshall NA; Barker RN; Vickers MA
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutics used in the treatment of leukemias].
    DEBRAY J
    Sem Hop; 1957 Feb; 33(11):664-6. PubMed ID: 13421789
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of acute leukemias and chronic myeloid leukemias].
    Devergie A
    Soins; 2008 Mar; (723):44-5. PubMed ID: 18380312
    [No Abstract]   [Full Text] [Related]  

  • 40. Current status of vaccination therapy for leukemias.
    Reichardt VL; Brossart P
    Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.